Literature DB >> 1879638

MRI of hepatic iron deposition in patients with renal transplant.

F H Miller1, M R Fisher, W Soper, R M Gore.   

Abstract

Excess hepatic iron deposition was found in five of 15 (33%) renal transplant patients undergoing magnetic resonance (MR) screening for avascular necrosis of the femoral heads. Only one of these patients had overt liver disease. The number of prior blood transfusions was a significant factor for this deposition, whereas the age and sex of the patients, number and type of transplants, histocompatibility alleles (HLA), and years of hemodialysis and of chronic renal failure were not significant etiological factors. Liver/fat intensity ratios of less than 0.29 on T1-weighted images and ratios of less than 0.21 on T2-weighted images and a calculated T2 value of less than 35 ms were the best indicators of iron overload. Renal transplant patients are at great risk for excess hepatic iron deposition and MR imaging is a promising tool for the diagnosis of iron overload in this patient population.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1879638     DOI: 10.1007/bf01887352

Source DB:  PubMed          Journal:  Gastrointest Radiol        ISSN: 0364-2356


  27 in total

1.  MR evaluation of liver iron overload.

Authors:  R J Hernandez; S A Sarnaik; I Lande; A M Aisen; G M Glazer; T Chenevert; W Martel
Journal:  J Comput Assist Tomogr       Date:  1988 Jan-Feb       Impact factor: 1.826

2.  Hemochromatosis resulting from prolonged oral iron therapy.

Authors:  B F Johnson
Journal:  N Engl J Med       Date:  1968-05-16       Impact factor: 91.245

3.  Nuclear magnetic resonance imaging of experimentally induced liver disease.

Authors:  D D Stark; N M Bass; A A Moss; B R Bacon; J H McKerrow; C E Cann; A Brito; H I Goldberg
Journal:  Radiology       Date:  1983-09       Impact factor: 11.105

4.  NMR imaging of the liver in two cases of iron overload.

Authors:  A W Leung; R E Steiner; I R Young
Journal:  J Comput Assist Tomogr       Date:  1984-06       Impact factor: 1.826

5.  Serum ferritin assay and iron status in chronic renal failure and haemodialysis.

Authors:  S Hussein; J Prieto; M O'Shea; A V Hoffbrand; R A Baillod; J F Moorhead
Journal:  Br Med J       Date:  1975-03-08

6.  Iron therapy in hemodialysis patients: time for a reappraisal.

Authors:  L E Human
Journal:  JAMA       Date:  1980-07-25       Impact factor: 56.272

7.  The detection of iron overload.

Authors:  C A Finch
Journal:  N Engl J Med       Date:  1982-12-30       Impact factor: 91.245

8.  Hemosiderosis and hemochromatosis in renal transplant recipients. Clinical and pathological features, diagnostic correlations, predisposing factors, and treatment.

Authors:  K V Rao; W R Anderson
Journal:  Am J Nephrol       Date:  1985       Impact factor: 3.754

9.  Serum ferritin in haemodialysis patients: role of blood transfusions and 'haemochromatosis alleles' HLA A3, B7 and B14.

Authors:  E Gómez; F Ortega; R Peces; E Gago; R Marín; J Alvarez Grande
Journal:  Nephron       Date:  1984       Impact factor: 2.847

10.  Hemosiderosis: an unrecognized complication in renal allograft recipients.

Authors:  K V Rao; W R Anderson
Journal:  Transplantation       Date:  1982-02       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.